Biote Corp. Class A Common Stock

BTMDNASDAQ • USD
1.13 USD
↗ 0.09 (8.65%)AT CLOSE (03:59 PM EDT)
1.15
↗ 0.02 (1.77%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.15
↗ 0.02 (1.77%)
🔴Market: CLOSED

Shares of Biote Corp. Class A Common Stock (BTMD) are trading at $1.13. Technical and fundamental signals converge bearish — technicals rate "Sell" while fundamentals read "Sell". This is driven by a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest BTMD is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Oct 14, 2026.

Open?$1.06
High?$1.21
Low?$1.06
Prev. Close?$1.04
Volume?144.8K
Avg. Volume?173.3K
VWAP?$1.14
Rel. Volume?0.84x
Bid / Ask
Bid?$0.97 × 100
Ask?$1.34 × 100
Spread?$0.37
Midpoint?$1.16
Valuation & Ratios
Market Cap?29.8M
Shares Out?28.7M
Float?21.7M
Float %?75.7%
P/E Ratio?5.09
P/B Ratio?-0.45
EPS?$0.20
Dividend?3.91%
Ex-Dividend?N/A
News
Profile
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Employees
223
Market Cap
29.8M
Industry
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Listed
2022-05-27
Address
1875 W. WALNUT HILL LN #100
IRVING, TX 75038
Phone: 972-486-9346
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
30
Momentum?
17
Short Sent.?
46
Piotroski F-Score?2/9Weak
Altman Z-Score?1.83Grey
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?4.99%Low
Short Interest?1.1M
Days to Cover?10.6
Free Float21.7M
Avg Daily Volume102.0K
Settlement Date2026-09-30
Financial Health
Current Ratio?1.43Adequate
Quick Ratio?0.82Weak
Cash Ratio?0.37Low
Debt/Equity?-1.85Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
5.1CHEAP▾
P/B?
S&P
97
-0.45CHEAP▾
P/S?
Peers
100
S&P
97
0.16CHEAP▾
P/FCF?
Peers
100
S&P
97
1.6CHEAP▾
EV/EBITDA?
Peers
100
S&P
92
7.5CHEAP▾
EV/Sales?
Peers
100
S&P
95
0.76CHEAP▾
Returns & Efficiency
ROE?
S&P
10
-8.9%WEAK▾
ROA?
Peers
50
S&P
51
5.8%FAIR▾
Cash Flow & Enterprise
FCF?$18.4M
Enterprise Value?$140.2M
Fundamentals ratios updated end of day